
Alzheimer's Disease
1st Edition
Understanding Biomarkers, Big Data, and Therapy
Secure Checkout
Personal information is secured with SSL technology.Free Shipping
Free global shippingNo minimum order.
Description
Nearly 44 million people have Alzheimer’s or a related dementia worldwide, according to the Alzheimer’s Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer’s and other forms of dementia. First, readers are introduced to the cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to symptoms and the quality of life in Alzheimer’s disease. In addition, some chapters discuss recent studies on memory dysfunction in advanced-stage Alzheimer’s disease, in comparison to early-stage Alzheimer’s disease, including a chapter on the factors underlying transition from mild cognitive impairment to Alzheimer’s disease. Following this section, some chapters present recent studies on the role of different cortical and subcortical structures in the development of different symptoms in Alzheimer’s disease as well as different neural biomarkers underlying the development and treatment of Alzheimer’s disease. In the last section of the book, therapeutic aspects of Alzheimer’s disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, in Alzheimer’s disease are reviewed. Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy aid readers with keeping up with the advances in research and care making it a prime tool for clinicians, psychologists, researcher, neurologists, and caregivers of dementia patients.
Key Features
- Reviews recent developments of cognitive and clinical studies
- Covers factors underlying transition from mild cognitive impairment to Alzheimer's disease
- Discusses different neural biomarkers underlying the development and treatment of Alzheimer's disease
- Provides a comparison on the effectiveness of various types of treatments
Readership
Advanced students and researchers in cognitive and behavioral neuroscience, psychology, psychiatry, psychotherapy, neurology
Table of Contents
- The types of memory dysfunction in Alzheimer’s disease
2. The prevalence of Depression in Alzheimer’s disease
3. Quality of life in Alzheimer’s disease
4. Cognitive and memory dysfunction in advanced-stage Alzheimer’s disease
5. Past and future thinking processes in Alzheimer’s disease
6. Factors underlying the transition from mild cognitive impairment to Alzheimer’s disease
7. Understanding the complexity and subtypes of Alzheimer’s disease
8. Different neural abnormalities in Alzheimer’s disease: dissociating the role of cortical and subcortical structures
9. Recent studies of behavioral and neural markers of different symptoms in Alzheimer’s disease
10. Enhancing autobiographical memory in Alzheimer’s disease
11. Cognitive training and mindlessness for the treatment of Alzheimer’s disease
12. The treatment of sleep disorders in Alzheimer’s disease
13. Pharmacological treatment for Alzheimer’ disease: recent advancement
14. The role of exercise and nutrition in the treatment of Alzheimer’s disease
Details
- No. of pages:
- 400
- Language:
- English
- Copyright:
- © Academic Press 2021
- Published:
- 1st September 2021
- Imprint:
- Academic Press
- Paperback ISBN:
- 9780128213346
About the Author

Ahmed Moustafa
Dr. Ahmed A. Moustafa is an associate professor of cognitive and behavioral neuroscience at the Marcs Institute for Brain, Behaviour, Development and School of Psychology, Western Sydney University, Sydney, Australia. Before joining Western Sydney University as a lab director, Dr. Moustafa spent 11 years in the United States studying psychology and neuroscience. His research focuses on computational and neuropsychological studies of addiction, schizophrenia, Alzheimer’s disease, PTSD, and depression. Dr. Moustafa’s works have been cited nearly 9000 times. He has published four books and more than 200 papers in high-ranking journals including Science, PNAS, Journal of Neuroscience, Brain, Neuroscience and Biobehavioral Reviews, Nature (Parkinson’s disease), and Neuron.
Affiliations and Expertise
Marcs Institute for Brain, Behaviour, Development and School of Psychology, Western Sydney University, Sydney, Australia
Ratings and Reviews
Request Quote
Tax Exemption
Elsevier.com visitor survey
We are always looking for ways to improve customer experience on Elsevier.com.
We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website.
Thanks in advance for your time.